Table 2.
End Points.*
Variable | Ablation Group (N = 64) | Control Group (N = 64) | Hazard Ratio (95% CI) | P Value |
---|---|---|---|---|
no. of patients (%) | ||||
ICD events* | 8 (12) | 21 (33) | 0.35 (0.15–0.78) | 0.007† |
ICD shocks | 6 (9) | 20 (31) | 0.27 (0.11–0.67) | 0.003† |
ICD storms | 4 (6) | 12 (19) | 0.30 (0.09–1.00) | 0.06‡ |
Death | 6 (9) | 11 (17) | 0.59 (0.22–1.59) | 0.29† |
Congestive heart failure | 3 (5) | 6 (9) | ||
Ventricular tachycardia storm | 0 | 1 (2) | ||
Cancer | 1 (2) | 0 | ||
Pulmonary embolism | 1 (2) | 0 | ||
Unknown | 1 (2) | 4 (6) |
Implantable cardioverter–defibrillator (ICD) events include ICD shocks and antitachycardia pacing.
The P value was calculated by the log-rank test.
The P value was calculated by Fisher’s exact test.